Success Metrics

Completion Rate
0%(0/2)
Active Trials
17(65%)
Terminated
2(8%)

Phase Distribution

Ph phase_1
26
100%

Phase Distribution

26

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution26 total trials
Phase 1Safety & dosage
26(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 6 finished

Non-Completion Rate

100.0%

6 ended early

Currently Active

17

trials recruiting

Total Trials

26

all time

Status Distribution
Active(19)
Terminated(6)
Other(1)

Detailed Status

Recruiting17
Withdrawn4
Not yet recruiting2
Terminated2
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
17
Success Rate
0.0%
Most Advanced
Phase 1

Trials by Phase

Phase 126 (100.0%)

Trials by Status

withdrawn415%
not_yet_recruiting28%
suspended14%
recruiting1765%
terminated28%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT05147675Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA

Recruiting
NCT05158127Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer

Not Yet Recruiting
NCT05147688Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases

Recruiting
NCT05016817Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF

Recruiting
NCT05018832Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI

Not Yet Recruiting
NCT05147779Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis

Recruiting
NCT05003921Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS

Suspended
NCT05018845Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD

Recruiting
NCT05018793Phase 1

Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI

Recruiting
NCT05147701Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION

Recruiting
NCT05003947Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD

Recruiting
NCT05003908Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes

Terminated
NCT06143527Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS

Recruiting
NCT05152381Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis

Withdrawn
NCT05003388Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS

Recruiting
NCT05016804Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis

Recruiting
NCT05018819Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP

Recruiting
NCT05152290Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI

Recruiting
NCT05003960Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism

Recruiting
NCT05003934Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA

Recruiting

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
26